IDSC 2025丨Professor Yoshiaki Gu: From National Action to One Health Strategy – Japan’s Experience and Future Pathways in AMR Control

IDSC 2025丨Professor Yoshiaki Gu: From National Action to One Health Strategy – Japan’s Experience and Future Pathways in AMR Control

ntimicrobial resistance (AMR) has become a major global public health challenge. To enhance capabilities in diagnosing and treating infectious diseases and promote rational use of antimicrobial agents in China, the 11th Academic Conference of the Infectious Diseases Society of China (IDSC) under the China Medicine Education Association was recently held in Beijing. At the conference, Professor Yoshiaki Gu from the Institute of Science Tokyo (Science Tokyo) shared Japan’s experience in AMR control. Infectious Disease Frontier invited Professor Gu to provide an in-depth analysis of the evolving threat of drug-resistant pathogens in Japan, the outcomes of its National Action Plan, and innovative public education initiatives. He further explored critical future directions for antimicrobial drug development and cross-sectoral collaboration under the "One Health" strategy.